You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SMALL MOLECULE INHIBITORS OF OCULAR NEOVASCULARIZATION

    SBC: LION PHARMACEUTICALS, INC.            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  2. Application of CDX-MDM in Pre-Clinical Model of Murine Pulmonary Emphysema

    SBC: Covenant Therapeutics LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): The objective of this proposal is to exploit a newly discovered anti-inflammatory function involving the aminopeptidase activity of the leukotriene A4 hydrolase for the treatment of pulmonary emphysema. The leukotrieneA4 hydrolase is a dual-functioning enzyme with dichotomously opposing functions. As an epoxide hydrolase, it catalyzes the conversion of leukotri ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. NEW TARGETS FOR ANTIGIARDIAL DRUGS

    SBC: Pharm-Eco Laboratories            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  4. INFECTION RESISTANT POLYURETHANE MATERIALS

    SBC: Cardiotech International, Inc.            Topic: N/A

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  5. Vaginal Ring for Preventing Bacterial Vaginosis

    SBC: REPROTECT, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Bacterial Vaginosis (BV) is an exceptionally common vaginal condition in which robust lactobacillus microflora in the vagina is replaced by a dense polymicrobial overgrowth. At any given time, about 1 in 3 women in the U.S. have BV; half are asymptomatic, and most women with symptomatic BV have only mild symptoms (increased discharge with a fishy smell). Despit ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Cell Sprayer for Chronic Wound Therapy

    SBC: PLUROGEN THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Chronic wounds, such as diabetic wounds, are a major global health and economic burden. In the United States alone, 10.8 million chronic wounds occur every year (de Zoysa et al., 2005) which is estimated to cost over 15 billion annually in the U.S. (Farley, 2005). Currently, the diabetes population in the United States is 20.8 million adults and children (Amer ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. High Productivity Eukaryotic Cell Culture Technology

    SBC: MEDICAL ROBOTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goals of this project are to develop a method to increase eukaryotic cell production and cell quality for research and drug discovery. We have preliminary data that demonstrates that we have developed a neutral buoyancy hydrogel based microcarrier process that can dramatically increase the density, viability, and diversity of cells available to researchers ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. BEHAVIORAL TECHNOLOGY FOR INSTRUCTIONAL READINESS

    SBC: PRAXIS, INC.            Topic: N/A

    This application seeks support for an STTR Phase I project to develop and study a computer software product for computer-managed evaluation and instruction with children who have severe mental retardation, autism, and other intellectual disabilities. The product is primarily targeted to those students who lack the behavioral prerequisites to participate in ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  9. PET Reagents for Normal and Tumor Tissue Hypoxia

    SBC: NATURAL PHARMACIA INTERNATIONAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Disruption of O2 gradients in normal tissues creates major medical problems including cardiovascular disease, stroke, diabetes, liver and kidney damage and organ transplant failure. Steep O2 gradients in tumors protect tumor cells from cytotoxic therapies and create more aggressive tumors. Measurements of O2 gradients are cle ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  10. New Topical Therapies for Psoriasis

    SBC: BETHESDA PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Psoriasis is a common, inflammatory disease of the skin characterized by hyperproliferation of keratinocytes. A variety of antipsoriatic therapies are available, however, due to problems with side effects and variability in clinical response, intense clinical and commercial interest remains in the development of new treatments. In the current studies, we will ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government